Bismuth subsalicylate
RxNorm 19478
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 19478 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: bismuth subsalicylate.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Bismuth subsalicylate
(Atom ID: 391551)
PTPrescribable
Designated preferred name (PT):
Bismuth subsalicylate
(Atom ID: 391557)
FNPrescribable
Full form of descriptor (FN):
Bismuth subsalicylate (substance)
(Atom ID: 391563)
PTPrescribable
Designated preferred name (PT):
Bismuth subsalicylate-containing product
(Atom ID: 10798199)
FNPrescribable
Full form of descriptor (FN):
Product containing bismuth subsalicylate (medicinal product)
(Atom ID: 9723569)
Patient Education
Bismuth Subsalicylate
Bismuth subsalicylate is used to treat diarrhea, heartburn, and upset stomach in adults and children 12 years of age and older. Bismuth subsalicylate is in a class of medications called antidiarrheal agents. It works by decreasing the flow of fluids and electrolytes into the bowel, reduces inflammation within the intestine, and may kill the organisms that can cause diarrhea.
[Learn More]
* Please review the disclaimer below.